The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.

The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.

Item
http://www.wikidata.org/entity/Q33750879
Nesiritide in acute decompensated heart failure: current status and future perspectivesROSE-AHF and lessons learned.Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy.The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigmsGenetic variation in the natriuretic peptide system and heart failure.B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetesGuanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.PARADIGM-HF trial: will LCZ696 change the current treatment of systolic heart failure?The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction.B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.Emerging Roles of Natriuretic Peptides and their Receptors in Pathophysiology of Hypertension and Cardiovascular RegulationDecompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide.Preoperative Cardiac Evaluation and Management of the Patient Undergoing Major Vascular Surgery.Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.Baseline NT-Pro-BNP levels and arrhythmia recurrence in outpatients undergoing elective cardioversion of persistent atrial fibrillation: a survival analysis.Atrial natriuretic peptide for the prevention of contrast-induced nephropathy: what's old is new but at the right dose and duration of therapy!
P2860

The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.

Item
http://www.wikidata.org/entity/Q33750879
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
@ast
The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
@en
type
label
The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
@ast
The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
@en
prefLabel
The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
@ast
The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
@en
P1433
P1476
P2093
P304
P31
P433
P478
P577
P698
P921
P1433
P1476
The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
@en
P2093
P304
P31
P433
P478
P577
P698
P921